Ryan Cross, who covers biotechnology for the Boston Globe, is leaving at the end of the month for a new opportunity covering the same beat.
“It was an incredible privilege to work at the paper, and it’s hard to say goodbye, but I’m excited to move to a rapidly growing publication to cover science and biotech in April,” he wrote on Twitter.
He covers the biotech industry and drug discovery for the Globe. He was previously a biotech reporter for Chemical & Engineering News where led coverage of COVID-19 vaccines. He has also written for MIT Technology Review and Science magazine.
Cross is a graduate of Boston University’s master’s program in science journalism, and he studied genetics and neuroscience at Purdue University.
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…